Irbesartan PCD Pharma Franchise Company
Cafoli Lifecare is a trusted Irbesartan PCD pharma franchise company offering 8 WHO-GMP certified Irbesartan formulations manufactured in DCGI-approved facilities. Our range is supplied to franchise partners across India with district-wise monopoly rights.
What is Irbesartan?
Irbesartan is an angiotensin II receptor blocker (ARB) that relaxes blood vessels by blocking the action of angiotensin II. It is used to treat hypertension and to protect the kidneys in type 2 diabetic nephropathy. Learn more on PubChem.
Available Irbesartan Formulations
Our Irbesartan portfolio spans 8 formulations across the following dosage forms: Tablets. As a prescription cardiovascular medicine, these are supplied against valid prescriptions.
Therapeutic Applications
Irbesartan is prescribed for hypertension and diabetic kidney disease. As a prescription cardiovascular medicine it is used under cardiologists, nephrologists, diabetologists and physicians.
Why Irbesartan is a High-Potential Molecule for Distributors
Hypertension is a lifelong condition, so ARBs like Irbesartan drive dependable monthly refills. Its renal-protective benefit in diabetic patients broadens the prescriber base and repeat demand for franchise partners.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers district-wise monopoly rights, WHO-GMP and DCGI-approved manufacturing, timely supply and complete promotional inputs. With 1000+ franchise partners, we back every associate marketing our Irbesartan range with reliable support.
References
- PubChem - Irbesartan
- PubMed - Irbesartan research
Our formulations of Irbesartan find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: